Form 8-K - Current report:
SEC Accession No. 0001213900-25-025735
Filing Date
2025-03-21
Accepted
2025-03-21 08:00:17
Documents
15
Period of Report
2025-03-18
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0235104-8k_pmgchold.htm   iXBRL 8-K 36517
2 PRESS RELEASE DATED MARCH 21, 2025 ea023510401ex99-1_pmgchold.htm EX-99.1 8202
3 FORM OF SECURITIES PURCHASE AGREEMENT DATED MARCH 18, 2025 ea023510401ex99-2_pmgchold.htm EX-99.2 57402
  Complete submission text file 0001213900-25-025735.txt   293594

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE elab-20250318.xsd EX-101.SCH 3027
5 XBRL LABEL FILE elab-20250318_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE elab-20250318_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0235104-8k_pmgchold_htm.xml XML 3797
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 25758546
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)